New Breast Cancer Rx to Be Given at Home

Featured July 15, 2020

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new breast cancer medication that can be given at home. This new medication is found under the

New Breast Cancer Rx Approved

Featured May 2, 2020

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new breast cancer medication. This new approval is called Trodelvy (sacituzumab govitecan-hziy). The FDA approved it to

New Breast Cancer Rx Gets Go-Ahead

Featured April 29, 2020

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new breast cancer medication. This new approval is called Tukysa (tucatinib). The FDA approved it to treat

Breast Cancer Rx Gets New Indication

Featured April 1, 2020

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new indication for a breast cancer drug. The medication is Nerlynx (neratinib). It is now approved to

New Breast Cancer Rx Gets Green Light

Featured January 2, 2020

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new medication to treat breast cancer. This new approval is called Enhertu (fam-trastuzumab deruxtecan-nxki). The FDA approved

Mammograms: What You Need to Know

Featured October 22, 2019

[ad_1] (RxWiki News) Mammograms can help detect breast cancer at an early stage. That means they can lead to early treatment, which can save lives. Early breast cancer treatment can

Mammogram Myths | RxWiki

Featured October 18, 2019

[ad_1] (RxWiki News) For Breast Cancer Awareness Month, we’re debunking four common mammogram myths. Mammograms are low-dose X-ray pictures of the breast. Because mammography can detect breast cancer tumors before

Another Biosimilar to Herceptin | RxWiki

Featured June 22, 2019

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved another biosimilar to a drug that treats breast, stomach and esophageal cancer. This biosimilar is called Kanjinti (trastuzumab-anns).

Breast Cancer Rx Now Approved for Men

Featured April 8, 2019

[ad_1] (RxWiki News) A breast cancer medication that was previously approved for women can now be used to treat men with advanced breast cancer. This medication is called Ibrance (palbociclib).

Another Biosimilar for a Common Breast Cancer Rx

Featured March 30, 2019

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved another biosimilar for a common breast cancer medication. The FDA recently approved Trazimera (trastuzumab-qyyp) to treat breast cancer.